Risk StewardRisk Steward
NOTES ON HEALTH, MONEY & A CHANGING WORLDPERSONAL PERSPECTIVES · MALAYSIA

A JOURNAL OF PERSPECTIVE

A changing world.
A judgement
of your own.

Progress gives us possibilities.
Perspective helps us choose.

Notes on health, money and the future—exploring what is changing, what we may have overlooked, and what it could mean for our lives.

TURN THE PERSPECTIVE

If we can detect more, what should we do differently?
Beh Risk Steward THE PERSON BEHIND THE PERSPECTIVE ↗

In focus

Fresh questions. Considered perspectives.

A NOTE FROM THE EDITOR

“I’m interested in a brighter future.
And the questions that help us prepare for it.”

Hope and preparation belong in the same conversation. This journal makes room for both.

A little more about Risk Steward ↗
Journal / Perspective

Health & Longevity

Could AI Transform Medicine? The Ideas Behind Solve Everything

Could AI help us overcome diseases that still shorten lives today? In Solve Everything: Achieving Abundance by 2035, Peter Diamandis and Alexander Wissner-Gross lay out an ambitious vision of that future. Their timeline is a projection, not a medical finding. [1]

Peter Diamandis is a physician and entrepreneur who founded XPRIZE, an organisation that uses competitions to tackle major challenges. Alexander (Alex) Wissner-Gross is a physicist, computer scientist and entrepreneur working in AI. [8] [9]

Three generations of a fictional family enjoying a morning walk in a leafy park.
More ordinary days together. AI-generated editorial illustration.

Where their optimism comes from

Their argument starts with a bottleneck: there are only so many experts, and research takes time. They believe increasingly capable, cheaper AI, connected to automated laboratories, could allow far more ideas to be developed and tested. [2]

For medicine, they imagine computer models of cells and organs that let researchers explore disease and possible treatments before testing them in people. They also envisage earlier prevention and organs made on demand. These are goals in their proposed future, not capabilities already available for every patient. [1]

In everyday terms, imagine being able to check thousands of possible solutions before choosing which ones to investigate in a laboratory. That could make the search more productive. The computer’s answer would still need to survive real-world testing.

There is real progress behind the idea

AlphaFold 3, published in 2024, predicts how proteins and other biological molecules fit together. That can help researchers understand interactions relevant to drug development. It predicts molecular structures; it does not demonstrate that a medicine cures a person. [3]

Another example is rentosertib, developed using AI to help identify a drug target and design a candidate for a serious lung-scarring disease. A 2025 study tested it in 71 patients in a randomized phase 2a trial, with safety as the main measure. That is meaningful progress into human testing, not proof of a cure. [4]

These examples help explain the optimism. They do not establish that most diseases will be cured by 2035. Safe, effective treatment and practical access remain separate hurdles; clinical testing and regulatory review still matter. [5]

What I take from it

I am hopeful about the direction, while keeping an open mind about the timetable. More illnesses becoming treatable could mean more ordinary days with family, more independence and more choices.

My response is to keep looking after today’s health, continue recommended care, and review our plans as the evidence develops. Even successful treatment can involve time away from work, with household bills continuing during recovery.

For those finding it difficult to build savings, affordable insurance can transfer some covered financial risks to an insurer while savings grow. Medical cover can help with eligible bills; a critical illness cash benefit can help with living costs when policy conditions are met. [6] [7] Start with existing support and what the budget can sustain. Future treatments are not automatically covered.

I welcome a future with better medicine. Preparing for it means protecting our choices today, without making our plans depend on a promised breakthrough date.

Sources

[1] Solve Everything: Achieving Abundance by 2035—authors’ vision and qualifications

[2] Alex Wissner-Gross: Explanation of the central argument, 14 February 2026

[3] Abramson et al., Nature (2024): AlphaFold 3 and biomolecular interactions

[4] Nature Medicine (2025): Randomized phase 2a rentosertib trial

[5] FDA: Drug development and review

[6] MyCoverage: Budget and medical insurance conditions

[7] EPF (KWSP): Types of insurance and critical illness cash benefits

[8] XPRIZE: Peter Diamandis—background

[9] Alexander Wissner-Gross: Background and research interests

Reviewed: 6 November 2026. General education and personal commentary. Research examples are distinct from the authors’ projections. Treatment and insurance eligibility depend on the person and applicable terms.

A QUESTION TO CARRY FORWARD

Original article ↗